ASO Visual Abstract: Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor Positive Breast Cancer Patients-Pathologic and Surgical Outcomes

被引：0
|
作者：
Cao, Lifen [1 ,2 ]
Sugumar, Kavin [1 ,2 ]
Keller, Eleanor [2 ,3 ]
Li, Pamela [1 ,2 ]
Rock, Lisa [1 ,2 ]
Simpson, Ashley [1 ,2 ]
Montero, Alberto J. [4 ]
Freyvogel, Mary [1 ,2 ]
Shenk, Robert [1 ,2 ]
Miller, Megan E. [1 ,2 ]
机构：
[1] Case Western Reserve Univ, Univ Hosp Cleveland, Med Ctr, Div Surg Oncol,Dept Surg,Sch Med, Cleveland, OH 44106 USA
[2] Univ Hosp Res Surg Outcomes & Effectiveness RISES, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[4] Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Div Hematol & Oncol,Dept Med,Med Ctr, Cleveland, OH 44106 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2021年 / 28卷 / SUPPL 3期
关键词：
D O I：
10.1245/s10434-021-10600-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：657 / 658
页数：2
相关论文
共 50 条
  • [1] ASO Visual Abstract: Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor Positive Breast Cancer Patients—Pathologic and Surgical Outcomes
    Lifen Cao
    Kavin Sugumar
    Eleanor Keller
    Pamela Li
    Lisa Rock
    Ashley Simpson
    Alberto J. Montero
    Mary Freyvogel
    Robert Shenk
    Megan E. Miller
    Annals of Surgical Oncology, 2021, 28 : 657 - 658
  • [2] Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor-Positive Breast Cancer Patients: Pathologic and Surgical Outcomes
    Cao, Lifen
    Sugumar, Kavin
    Keller, Eleanor
    Li, Pamela
    Rock, Lisa
    Simpson, Ashley
    Freyvogel, Mary
    Montero, Alberto J.
    Shenk, Robert
    Miller, Megan E.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (10) : 5730 - 5741
  • [3] Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor-Positive Breast Cancer Patients: Pathologic and Surgical Outcomes
    Cao, Lifen
    Sugumar, Kavin
    Simpson, Ashley
    Rock, Lisa
    Li, Pamela
    Freyvogel, Mary
    Dietz, Jill
    Montero, Alberto Jose
    Shenk, Robert
    Miller, Megan E.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 2) : S243 - S244
  • [4] Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor-Positive Breast Cancer Patients: Pathologic and Surgical Outcomes
    Lifen Cao
    Kavin Sugumar
    Eleanor Keller
    Pamela Li
    Lisa Rock
    Ashley Simpson
    Mary Freyvogel
    Alberto J. Montero
    Robert Shenk
    Megan E. Miller
    Annals of Surgical Oncology, 2021, 28 : 5730 - 5741
  • [5] ASO Visual Abstract: Neoadjuvant Chemotherapy and Endocrine Therapy for Older Patients with Estrogen Receptor Positive Breast Cancer—Comparison of Approaches
    Krislyn N. Miller
    Samantha M. Thomas
    Sydney M. Record
    Laura H. Rosenberger
    Maggie L. DiNome
    Gayle DiLalla
    Jeremy M. Force
    E. Shelley Hwang
    Jennifer K. Plichta
    Annals of Surgical Oncology, 2023, 30 : 6151 - 6151
  • [6] Impact of neoadjuvant chemotherapy on surgical outcomes among patients with hormone receptor positive breast cancer
    Hage, Andrew N.
    Capriccioso, Christina
    Brennan, Julia
    Heiden, Brendan
    Zheutlin, Alexander
    Sabel, Michael S.
    JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (06) : 665 - 670
  • [7] ASO Visual Abstract: Discordant Breast and Axillary Pathologic Response to Neoadjuvant Chemotherapy
    Rene Flores
    Estefania Roldan
    Jaime A. Pardo
    Leah Beight
    Jessalyn Ubellacker
    Betty Fan
    Roger B. Davis
    Ted A. James
    Annals of Surgical Oncology, 2023, 30 : 8467 - 8468
  • [8] ASO Visual Abstract: Mutational Status is Associated with Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer
    Sara P. Myers
    Varadan Sevilimedu
    Andrea V. Barrio
    Audree B. Tadros
    Anita Mamtani
    Mark E. Robson
    Monica Morrow
    Minna K. Lee
    Annals of Surgical Oncology, 2023, 30 : 8469 - 8470
  • [9] ASO Visual Abstract: Mutational Status is Associated with Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer
    Myers, Sara P.
    Sevilimedu, Varadan
    Barrio, Andrea V.
    Tadros, Audree B.
    Mamtani, Anita
    Robson, Mark E.
    Morrow, Monica
    Lee, Minna K.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (13) : 8469 - 8470
  • [10] ASO Visual Abstract: Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer
    Verdial, Francys C.
    Mamtani, Anita
    Pawloski, Kate R.
    Sevilimedu, Varadan
    D'Alfonso, Timothy M.
    Zhang, Hong
    Gemignani, Mary L.
    Barrio, Andrea, V
    Morrow, Monica
    Tadros, Audree B.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (06) : 3820 - 3821
12345